Company / Current Liabilities
Coherus Oncology, Inc. Current Liabilities History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$115.0M
FY2019
5-year range
$28.4M / $115.0M
FY2015-FY2019
Trend
+245.7%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities changed +246% YoY in FY2019, a notable deviation from the 5-year average annual change of +54%.
Based on SEC 10-K filings.
$115M in FY2019 with a 5-year CAGR of +17.3%.
Increased from $28M to $115M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +26.8%
- 5-Year CAGR
- +17.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +17.3%, indicating consistent growth.
- In FY2019, current liabilities increased 245.7% year-over-year.
- Lowest current liabilities in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $115.0M | +245.7% |
| FY2018 | $33.3M | +17.1% |
| FY2017 | $28.4M | -49.6% |
| FY2016 | $56.4M | -46.8% |
| FY2015 | $106.0M | +104.7% |
| FY2014 | $51.8M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026